Eli Lilly and Co Newsroom

Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com

Barron'sJul 22 08:58 ET

HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating

MT NewswiresJul 19 08:25 ET

TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850

MT NewswiresJul 17 09:33 ET

Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793

MT NewswiresJul 16 08:19 ET

Eli Lilly and Co Analyst Ratings

BenzingaJul 15 09:08 ET

Eli Lilly & Co (LLY) Gets a Buy From Barclays

TipRanksJul 15 03:56 ET

UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating

MT NewswiresJul 12 09:41 ET

Berenberg Maintains Buy on Eli Lilly and Co, Raises Price Target to $1000

BenzingaJul 11 12:42 ET

Berenberg Adjusts Price Target on Eli Lilly & Co. to $1,000 From $850, Maintains Buy Rating

MT NewswiresJul 11 06:11 ET

Eli Lilly and Co Analyst Ratings

BenzingaJul 10 19:28 ET

Barclays Remains a Buy on Eli Lilly & Co (LLY)

TipRanksJul 8 03:57 ET

Eli Lilly and Co Analyst Ratings

BenzingaJul 5 09:36 ET

Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating

MT NewswiresJul 3 05:38 ET

Eli Lilly and Co Analyst Ratings

BenzingaJul 1 11:12 ET

Eli Lilly and Co Analyst Ratings

BenzingaJun 26 12:11 ET

Truist Securities Reiterates Buy on Eli Lilly and Co, Raises Price Target to $1000

BenzingaJun 25 09:12 ET

Eli Lilly and Co Analyst Ratings

BenzingaJun 24 10:47 ET

Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994

MT NewswiresJun 24 06:15 ET

Eli Lilly and Co Analyst Ratings

BenzingaJun 17 13:25 ET

Eli Lilly and Co Analyst Ratings

BenzingaJun 11 12:28 ET